Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
You are already at the latest version Background: ctDNA-based NGS MRD testing in breast cancer faces a critical but overlooked limitation: low-frequency somatic mutations from normal aging non-malignant tissues—beyond clonal hematopoiesis—contaminate plasma ctDNA at levels indistinguishable from true MRD signals, creating a specificity ceiling that increased sequencing depth cannot resolve.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
